Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 7/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 2/20 | 0.33 |
| ▸ | HTR2A | P28223 | 2/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL51655 | 0.91 | SIGMAR1 (0.34) | LMNAHTR1ASIGMAR1 | |
| SCHEMBL51966 | 0.85 | HRH3 (0.37) | HTR7LMNAHTTNPSR1L3MBTL1 | |
| SCHEMBL52657 | 0.82 | ALDH1A1 (0.41) | HTR7SIGMAR1 | |
| SCHEMBL51395 | 0.81 | ALDH1A1 (0.43) | HTR7SIGMAR1 | |
| SCHEMBL52616 | 0.81 | ALDH1A1 (0.45) | HTR7SIGMAR1 | |
| SCHEMBL51659 | 0.80 | MEN1 (0.38) | HTR7HTR2ASIGMAR1OPRL1 | |
| SCHEMBL52356 | 0.80 | CYP3A4 (0.32) | SIGMAR1 | |
| SCHEMBL2168243 | 0.76 | ALDH1A1 (0.50) | HTR7HTR1AHTR2ASIGMAR1DRD2 | |
| SCHEMBL652976 | 0.70 | HTR7 (0.60) | HTR7HTR1AHTR2ADRD2SLC6A4 | |
| SCHEMBL13255330 | 0.68 | CCR3 (0.59) | HTR7SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8426596-B2 | Process of producing bleach boosters | BASF AKTIENGESELLSCHAFT (DE) | 2013-04-23 | — | — | US | disclosed |
| US-8129531-B2 | Using an isoquinoline compound; alkylation of benzonitrile; reduction ofnitrile to an amine; cyclization | BASF AKTIENGESELLSCHAFT (DE) | 2012-03-06 | — | — | US | disclosed |
| US-20110319622-A1 | PROCESS OF PRODUCING BLEACH BOOSTERS | BASF SE (DE) | 2011-12-29 | — | — | US | disclosed |
| EP-1891192-B1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | PROCTER & GAMBLE (US) | 2009-12-16 | — | — | EP | disclosed |
| US-20090149366-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | MIRACLE GREGORY SCOT | 2009-06-11 | — | — | US | disclosed |
| US-7504371-B2 | Organic catalyst with enhanced enzyme compatibility | THE PROCTER & GAMBLE COMPANY (US) | 2009-03-17 | — | — | US | disclosed |
| US-20080214819-A1 | Process of Producing Bleach Boosters | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-04 | — | — | US | disclosed |
| EP-1891192-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | The Procter and Gamble Company (US) | 2008-02-27 | — | — | EP | disclosed |
| US-20070197421-A1 | Organic catalyst with enhanced enzyme compatibility | PROCTER & GAMBLE COMPANY, THE | 2007-08-23 | — | — | US | disclosed |
| WO-2007001261-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-04 | — | — | WO | disclosed |
| US-20060287210-A1 | Organic catalyst with enhanced enzyme compatibility | PROCTER & GAMBLE COMPANY, THE | 2006-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214819-A1 | Process of Producing Bleach Boosters | SQLE, BCHE, CAT | HTR7 2680/4885LMNA 3583/4885HTT 383/4885 |
| US-20060287210-A1 | Organic catalyst with enhanced enzyme compatibility | AOX1, ACHE, MPO | HTR7 3638/4885LMNA 4408/4885HTT 3296/4885 |
| US-20110319622-A1 | PROCESS OF PRODUCING BLEACH BOOSTERS | SQLE, BCHE, CAT | HTR7 2680/4885LMNA 3583/4885HTT 383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.